LBSG3B06013: Difference between revisions
No edit summary |
(No difference)
|
Latest revision as of 09:00, 21 November 2017
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
{{#googleapi:}}
| Glycosphingolipid | |||
|---|---|---|---|
|
| |||
| Blood group A, Aa-glycolipid, Type 2 IV3GalNAca, IV2Fuca-nLc4Cer | |||
| Composition | 06 sugars | ||
| and Phyletic groups in the references | Canis (Mammalia); Sus (Mammalia); Homo (Primates); | ||
| Distribution | |||
| Dog small intestine;Hog gastric mucosa;Human Fabry disease patient skin fibroblast;Human Schinder disease patient skin fibroblast;Human erythrocyte;Humna gatric cancer cell MKN45;Human pancreas, Human lung | |||
| Old LipidBank ID | - | ||
| Reported Metabolites, References | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|